SMYD3 and cancer: Additional methylation-linked transcriptional control comes via SET and MYND domain-containing protein 3 (SMYD3), a histone methyltransferase, which can bind to the TERT promoter and activate TERT transcription through histone H3K4 dimethylation or trimethylation in human fibroblasts and cancer cells [156].